Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.
Expansion Therapeutics has raised $6.9M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in January 2023.
Expansion Therapeutics's investors include RA Capital Management, Cormorant Asset Management, Kleiner Perkins, 5AM Ventures, Alexandria Venture Investments.
Expansion Therapeutics is headquartered in San Diego, United States.
Expansion Therapeutics is a biotechnology company focusing on developing transformative oral medicines for severe RNA-mediated diseases.
Expansion Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Expansion Therapeutics — Funding & Investors." VCBacked, January 4, 2023, https://www.vcbacked.co/company/expansion-therapeutics. Accessed July 19, 2026.
VCBacked. (2023). Expansion Therapeutics — Funding & Investors. Retrieved July 19, 2026, from https://www.vcbacked.co/company/expansion-therapeutics
{{cite web |title=Expansion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/expansion-therapeutics |website=VCBacked |access-date=July 19, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated